Nobilis Health Corp.
NRTSF
$0.00
$0.000.00%
OTC PK
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | 272.53M | 284.38M | 288.05M | 306.64M | 313.19M |
| Total Other Revenue | 9.14M | 8.06M | 9.27M | 8.58M | 8.06M |
| Total Revenue | 281.67M | 292.44M | 297.32M | 315.22M | 321.25M |
| Cost of Revenue | 109.45M | 110.76M | 112.69M | 113.92M | 116.48M |
| Gross Profit | 172.21M | 181.68M | 184.63M | 201.30M | 204.77M |
| SG&A Expenses | 136.17M | 144.78M | 150.42M | 164.49M | 171.12M |
| Depreciation & Amortization | 16.31M | 13.91M | 11.60M | 10.20M | 9.42M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 261.93M | 269.45M | 274.71M | 288.61M | 297.02M |
| Operating Income | 19.74M | 22.99M | 22.61M | 26.61M | 24.23M |
| Income Before Tax | 19.92M | 23.19M | 23.28M | 21.55M | 19.83M |
| Income Tax Expenses | 12.09M | 13.85M | 13.00M | 6.88M | 7.43M |
| Earnings from Continuing Operations | 7.83 | 9.35 | 10.28 | 14.66 | 12.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.19M | -7.00M | -6.48M | -5.10M | -6.61M |
| Net Income | 1.64M | 2.34M | 3.80M | 9.57M | 5.80M |
| EBIT | 19.74M | 22.99M | 22.61M | 26.61M | 24.23M |
| EBITDA | 36.05M | 36.90M | 34.21M | 36.81M | 33.65M |
| EPS Basic | 0.02 | 0.03 | 0.05 | 0.12 | 0.08 |
| Normalized Basic EPS | 0.07 | 0.08 | 0.09 | 0.11 | 0.08 |
| EPS Diluted | 0.02 | 0.03 | 0.05 | 0.12 | 0.07 |
| Normalized Diluted EPS | 0.07 | 0.08 | 0.09 | 0.11 | 0.08 |
| Average Basic Shares Outstanding | 312.17M | 311.79M | 311.41M | 310.49M | 309.46M |
| Average Diluted Shares Outstanding | 316.72M | 312.68M | 312.30M | 311.90M | 310.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |